The Keosys Blog

Keosys Jul 20, 2021

Keo-Tales: Introducing the Keosys Interns

Every year, Keosys takes on a select number of interns, giving them the..

Keosys Jul 13, 2021

Central Review According to iRECIST in Cancer Immunotherapy Clinical Trials

This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..

Keosys Jun 24, 2021

iRECIST and Tumor Response to Immunotherapy with Infographic

iRecist and Tumor Response to Immunotherapy When immunotherapy is used to treat..

Keosys Jun 23, 2021

Keo-Tales: Looking Back and Looking Forward

Keosys is an imaging solutions provider supporting biopharmaceutical companies..

Keosys Jun 15, 2021

Read Criteria and the Evaluation of Antitumor Responses With Immunotherapeutic Agents

This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..

Keosys Mar 31, 2021

Imaging CROs Role in Clinical Research with Infographic

The use of imaging endpoints in clinical trials has steadily grown over the..

Keosys Mar 30, 2021

Project Manager Stephanie Graf Joins the Keosys Team in the US

We are pleased to welcome Stephanie Graf to our Project Management team in the..

Keosys Mar 23, 2021

Interview: Cancer Insight Leverages a Surgical Oncologist's Long Commitment to Service and Research

We recently spoke with George E. Peoples, M.D., founder and Chief Executive..

Keosys Feb 19, 2021

Interview: Global Perspectives from a Global Powerhouse, Syneos Health

We recently spoke with Patrick Nealon, Executive Vice President and General..

Gianmarco Santini, PhD | Research Scientist Jan 27, 2021

Medical Imaging Data Synthesis using Generative Adversarial Networks

Combining different modalities as done with PET/CT, clinical decision making is..

Noémie Moreau | PhD Research Scientist Jan 14, 2021

Deep Learning Approaches for Bone and Bone Lesion Segmentation on 18FDG PET/CT Imaging in the Context of Metastatic Breast Cancer

Introduction In the context of metastatic breast cancer, tumor segmentation can..

Keosys Dec 11, 2020

Interview: OncoBay Clinical Redefines What's Possible for CROs

We recently spoke with OncoBay Clinical executives Krystyna Kowalczyk, CEO, and..

Previous All posts Next

Recent